A research team led by investigators from the National Institutes of Health and Global Good has developed a computer algorithm that can analyze digital images of a woman’s cervix and accurately identify precancerous changes that require medical attention.
This artificial intelligence (AI) approach, called automated visual evaluation, has the potential to revolutionize cervical cancer screening, particularly in low-resource settings.
To develop the method, researchers used comprehensive datasets to “train” a deep, or machine, learning algorithm to recognize patterns in complex visual inputs, such as medical images. The approach was created collaboratively by investigators at the National Cancer Institute (NCI) and Global GoodExit Disclaimer, a fund at Intellectual Ventures, and the findings were confirmed independently by experts at the National Library of Medicine (NLM). The results appeared in the Journal of the National Cancer Institute on January 10, 2019. NCI and NLM are parts of NIH.
“Our findings show that a deep learning algorithm can use images collected during routine cervical cancer screening to identify precancerous changes that, if left untreated, may develop into cancer,” said Mark Schiffman, M.D., M.P.H., of NCI’s Division of Cancer Epidemiology and Genetics, and senior author of the study. “In fact, the computer analysis of the images was better at identifying precancer than a human expert reviewer of Pap tests under the microscope (cytology).”
The new method has the potential to be of particular value in low-resource settings. Health care workers in such settings currently use a screening method called visual inspection with acetic acid (VIA). In this approach, a health worker applies dilute acetic acid to the cervix and inspects the cervix with the naked eye, looking for “aceto whitening,” which indicates possible disease. Because of its convenience and low cost, VIA is widely used where more advanced screening methods are not available. However, it is known to be inaccurate and needs improvement.
Automated visual evaluation is similarly easy to perform. Health workers can use a cell phone or similar camera device for cervical screening and treatment during a single visit. In addition, this approach can be performed with minimal training, making it ideal for countries with limited health care resources, where cervical cancer is a leading cause of illness and death among women.
To create the algorithm, the research team used more than 60,000 cervical images from an NCI archive of photos collected during a cervical cancer screening study that was carried out in Costa Rica in the 1990s. More than 9,400 women participated in that population study, with follow up that lasted up to 18 years. Because of the prospective nature of the study, the researchers gained nearly complete information on which cervical changes became precancers and which did not. The photos were digitized and then used to train a deep learning algorithm so that it could distinguish cervical conditions requiring treatment from those not requiring treatment.
Overall, the algorithm performed better than all standard screening tests at predicting all cases diagnosed during the Costa Rica study. Automated visual evaluation identified precancer with greater accuracy (AUC=0.91) than a human expert review (AUC=0.69) or conventional cytology (AUC=0.71). An AUC of 0.5 indicates a test that is no better than chance, whereas an AUC of 1.0 represents a test with perfect accuracy in identifying disease.
“When this algorithm is combined with advances in HPV vaccination, emerging HPV detection technologies, and improvements in treatment, it is conceivable that cervical cancer could be brought under control, even in low-resource settings,” said Maurizio Vecchione, executive vice president of Global Good.
The researchers plan to further train the algorithm on a sample of representative images of cervical precancers and normal cervical tissue from women in communities around the world, using a variety of cameras and other imaging options. This step is necessary because of subtle variations in the appearance of the cervix among women in different geographic regions. The ultimate goal of the project is to create the best possible algorithm for common, open use.
The Latest on: Cervical cancer
via Google News
The Latest on: Cervical cancer
- Check the common signs of cancer to give yourself and your family an MOTon February 27, 2021 at 4:27 pm
FINDING and treating cancer early saves lives – fact. But as coronavirus continues to put pressure on the NHS, there are fears that those with symptoms are putting off a visit to their GP, with 3 ...
- GPs scolded for refusing to book cervical cancer screeningson February 27, 2021 at 4:01 pm
GPs have been warned to stop snubbing thousands of women seeking cervical cancer checks amid concern that lives are being put at risk.In an email to family doctors, NHS chiefs report complaints from ...
- Family of Joan Lucey, who died of cervical cancer, ‘saddened and frustrated’ over High Court caseon February 26, 2021 at 11:25 pm
The family of a grandmother who died of cervical cancer while pursuing a court claim over incorrect smear test results has settled her High Court action. Former nurse Joan Lucey, 73, from Cooleen, ...
- Ethiopia: Graduates Vow to Contain Cervical Cancer Amid Pandemicon February 26, 2021 at 5:40 am
Recently graduated physicians have pledged to reduce cervical cancer health complications via providing the public with quality health service despite COVID-19 pandemic and work-related challenges.
- Virus against virus: strategies for using adenovirus vectors in the treatment of HPV-induced cervical canceron February 25, 2021 at 6:56 am
Although most human papillomavirus (HPV) infections are harmless, persistent infection with high-risk types of HPV is known to be the leading cause of cervical cancer. Following the infection of the ...
- The deubiquitinase (DUB) USP13 promotes Mcl-1 stabilisation in cervical canceron February 24, 2021 at 3:31 am
For example, defects in ubiquitin-mediated proteasomal degradation can result in either the enhanced degradation of tumour suppressor proteins, or in the stabilisation of oncogenes [ 4 ].
- Home smear tests trialled by NHS to encourage DIY cervical cancer screeningon February 24, 2021 at 3:20 am
Women aged 25-64 years who are 15 months overdue for a check and live in Barnet, Camden, Islington, Newham and Tower Hamlets will be contacted ...
- Thousands of women to trial at-home smear tests in bid to cut cervical canceron February 24, 2021 at 12:51 am
Many women don't come forward for the test due the 'embarrassment factor' and the problem has been exasperated by the pandemic.
- London women to be offered at-home smear test kits in NHS bid to cut cervical cancer rateson February 24, 2021 at 12:41 am
London are to trial at-home smear tests in a bid to cut the number of cervical cancers. More than 31,000 women will be given kits to carry out the tests in their own home, rather than having the test ...
- Scots mum, 32, devastated as she’s given a year to live after cervical cancer spread to lungson February 23, 2021 at 2:01 pm
A SCOTS mum is devastated as she was given a year to live after her cervical cancer spread to her lungs. Rachel Kennedy, 32, is raising funds for alternative treatments as she desperately hunts ...
via Bing News